HHS’ Drug Pricing Plan Noncommittal On March-In; Omits Intl. Prices

By Gabrielle Wanneh / September 9, 2021 at 5:41 PM
HHS’ plan for controlling drug prices includes many policies that Democrats have wanted for years, including Medicare drug price negotiation, but HHS did not take a position on whether it would use march-in rights, and it didn’t mention tying U.S. drug prices to those abroad, which the Trump administration pursued. HHS Secretary Xavier Becerra on Thursday (Sept. 9) released a plan to cut prescription drug costs that was required by a presidential executive order . The department calls on Congress...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.